Alamar Biosciences Files Initial Ownership Statement
Ticker: ALMR · Form: 3 · Filed: Apr 17, 2026
Sentiment: neutral
Topics: insider-filing, ownership, sec-filing
TL;DR
Alamar Biosciences just filed a Form 3 - initial ownership report. Transparency incoming.
AI Summary
On April 16, 2026, Alamar Biosciences, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. This filing indicates the initial reporting of ownership for certain individuals or entities within the company. The filing was made with the SEC and is publicly available.
Why It Matters
This filing marks the initial public disclosure of beneficial ownership of securities for Alamar Biosciences, Inc., providing transparency for investors regarding who holds significant stakes in the company.
Risk Assessment
Risk Level: low — A Form 3 filing is a standard regulatory requirement for initial beneficial ownership reporting and does not inherently indicate financial risk.
Key Players & Entities
- Alamar Biosciences, Inc. (company) — Issuer
- Rebecca Chambers (person) — Reporting Person
- VERACYTE, INC. (company) — Mailing Address Recipient
FAQ
What type of filing is this?
This is a Form 3, an initial statement of beneficial ownership of securities.
When was the filing date?
The filing date was April 16, 2026.
Who is the issuer?
The issuer is Alamar Biosciences, Inc.
What is the CIK for Alamar Biosciences, Inc.?
The CIK for Alamar Biosciences, Inc. is 0002104204.
What is the mailing address listed for the company?
The mailing address is C/O VERACYTE, INC. 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 17, 2026 by Rebecca Chambers regarding Alamar Biosciences, Inc. (ALMR). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.